Real-world outcomes in patients with chronic obstructive pulmonary disease initiating long-acting mono bronchodilator therapy | Zendy

Lindsay G.S. Bengtson | Zendy; Michael DePietro | Zendy; Jeffrey McPheeters | Zendy; Kathleen M. Fox | Zendy

Open Access

Real-world outcomes in patients with chronic obstructive pulmonary disease initiating long-acting mono bronchodilator therapy

Author(s) -

Lindsay G.S. Bengtson,

Michael DePietro,

Jeffrey McPheeters,

Kathleen M. Fox

Publication year - 2018

Publication title -

therapeutic advances in respiratory disease

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.022

H-Index - 37

eISSN - 1753-4666

pISSN - 1753-4658

DOI - 10.1177/1753466618772750

Subject(s) - medicine , bronchodilator , copd , discontinuation , bronchodilator agents , health care , intensive care medicine , physical therapy , emergency medicine , asthma , economics , economic growth

Patients initiating long-acting mono bronchodilator therapy had high rates of medication discontinuation or augmentation. Patients used more rescue medications and experienced significantly more COPD exacerbations with higher healthcare costs compared with baseline. Further research is warranted to determine whether more aggressive initial therapy would result in symptom improvement.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research